eu-logo

This project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 101008548

  • About the project
    • Motivation
    • Description
  • Transnational Access
    • Closure of RESEARCH Transnational Access (TNA) Applications
    • Transnational Access Form – Clinical access
  • Consortium
  • Research Community
  • Industry
    • Get in touch
    • Technology Matching Event
  • Training & events
    • Current events
    • e-learning courses
    • Past Events
  • Careers
  • Publications
    • Publications
    • Newsletter archive
  • Log in

    • Profile
    • Log-out
  • About the project
    • Motivation
    • Description
  • Transnational Access
    • Closure of RESEARCH Transnational Access (TNA) Applications
    • Transnational Access Form – Clinical access
  • Consortium
  • Research Community
  • Industry
    • Get in touch
    • Technology Matching Event
  • Training & events
    • Current events
    • e-learning courses
    • Past Events
  • Careers
  • Publications
    • Publications
    • Newsletter archive
  • Log in

    • Profile
    • Log-out

HITRIplus News

  • Date

The Hadron Academy. Risk and complexity in high tech medical innovation

The Hadron Academy. Risk and complexity in high tech medical innovation

Mar 16, 2023 |

3rd Specialized Course on Clinical Aspects of Heavy Ion Therapy Research

3rd Specialized Course on Clinical Aspects of Heavy Ion Therapy Research

Mar 9, 2023 |

10th Seminar of HITRIplus – Helium Ion Beam Therapy

10th Seminar of HITRIplus – Helium Ion Beam Therapy

Feb 14, 2023 |

9th Seminar of HITRIplus –  FLASH radiotherapy with Carbon ions: is it possible to combine high LET and FLASH benefits? Experimental and modeling studies

9th Seminar of HITRIplus – FLASH radiotherapy with Carbon ions: is it possible to combine high LET and FLASH benefits? Experimental and modeling studies

Dec 20, 2022 |

8th Seminar of HITRIplus – The Past, Present, and Future of CIRT for Cervical Cancer: Implementation of “Immuno-CIRT” considering the radiation-induced anti-tumor immune response

8th Seminar of HITRIplus – The Past, Present, and Future of CIRT for Cervical Cancer: Implementation of “Immuno-CIRT” considering the radiation-induced anti-tumor immune response

Oct 19, 2022 |

Time to attend at ICRI 2022 Side Event

Time to attend at ICRI 2022 Side Event

Oct 13, 2022 |

Specialised Course on Heavy Ion Cancer Therapy Research

Specialised Course on Heavy Ion Cancer Therapy Research

Jun 7, 2022 |

2nd HITRIplus Project Meeting

2nd HITRIplus Project Meeting

May 31, 2022 |

DISCOVER HEAVY ION THERAPY: A NEXT GENERATION TOOL AGAINST CANCER

DISCOVER HEAVY ION THERAPY: A NEXT GENERATION TOOL AGAINST CANCER

Apr 28, 2022 |

7th Seminar of HITRIplus – Health – value of particle therapy in 2022: clinical evidences and innovative opportunities

7th Seminar of HITRIplus – Health – value of particle therapy in 2022: clinical evidences and innovative opportunities

Apr 20, 2022 |

« Older Entries
Next Entries »
eu-logo

This project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 101008548

Legal information

HITRIplus coordinator in charge of managing this website is Fondazione CNAO.

Strada Campeggi 53, 27100 – Pavia (Italy)

P.IVA 03491780965

Contacts

E-mail: info@hitriplus.eu

E-mail: press@hitriplus.eu

Quick link

Research Community

Internships

Job Opportunities

TNA

Clinical Access

Research Access

 

Media & Communication

Latest news

Press release and articles

Events

Multimedia

Newsletter

Newsletters Subscription


Newsletters subscription information

Filling in the form below you can request to be subscribed to HITRIplus general newsletter in order to receive, via email, information and news about the activities of the HITRIplus Project, including invitations to participate in events or surveys and fund raising campaigns. For more information, please consult our Privacy Policy Page


loader


Social

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Privacy Policy